Nivolumab plus Ipilimumab in Microsatellite-Instability-High Metastatic Colorectal Cancer
{{output}}
Background: Patients with microsatellite-instability-high (MSI-H) or mismatch-repair-deficient (dMMR) metastatic colorectal cancer have poor outcomes with standard chemotherapy with or without targeted therapies. Nivolumab plus i... ...
